Fulgent Genetics (FLGT) Stock Statistics & Valuation Metrics

Fulgent Genetics has a market cap or net worth of $671.87M. The enterprise value is $317.26M.

Fulgent Genetics has 30,609,043 shares outstanding. The number of shares has decreased by -2.65% in one year.

Fulgent Genetics’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.43%.

The current PE Ratio of Fulgent Genetics is ―. Fulgent Genetics’s PEG ratio is ―.

In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.

In the last 12 months, operating cash flow was -25.09M and capital expenditures -34.86M, giving a free cash flow of -59.95M billion.

Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―

Fulgent Genetics upcoming earnings date is Nov 5, 2025, After Close (Confirmed).

Fulgent Genetics as a current ratio of 4.85, with Debt / Equity ratio of 0.66%

In the past 12 months, Fulgent Genetics has paid -8.14M in taxes.

Fulgent Genetics EV to EBITDA ratio is -10.46, with an EV/FCF ratio of -26.62.

Fulgent Genetics has $292.93M in cash and marketable securities with $7.39M in debt, giving a net cash position of -$285.54M billion.

Gross margin is 40.04%, with operating margin of -26.08%, and net profit margin of -15.07%.

The average price target for Fulgent Genetics is $24.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy